Intravitreal methotrexate as an adjunctive treatment of intraocular lymphoma

Archives of Ophthalmology

Volumn 115, Issue 9, 1997, Pages 1152-1156

  Fishbume, Barren C ^a,b   Wilson, David J ^a   Rosenbaum, James T ^b   Neuwdt, Edward A ^c  

^a or 97239 4197   (United States)

^b Department of Medicine ^*  (United States)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METHOTREXATE;

ADULT; AGED; ARTICLE; BLOOD BRAIN BARRIER; CANCER RADIOTHERAPY; CASE REPORT; FEMALE; FOLLOW UP; HUMAN; INTRAOCULAR TUMOR; INTRAVITREAL DRUG ADMINISTRATION; LYMPHOMA; MALE; PRIORITY JOURNAL; SURVIVAL RATE; TUMOR BIOPSY; TUMOR RECURRENCE; VISUAL ACUITY; VITRECTOMY;

EID: 0030924161     PISSN: 00039950     EISSN: None     Source Type: Journal    
DOI: 10.1001/archopht.1997.01100160322009     Document Type: Article

References (16)

1. Roos DE, O'Brien PC, Crompton JL Ocular involvement in primary central nervous system lymphoma: an increasing clinical problem? Australas Radial. 1993; 37:372-374.
2. Eby NL, Grufferman S, Flannelly CM, Schuld SC Jr, Vogel FS, Burger PC. Increasing incidence of primary brain lymphoma in the US. Cancer. 1988;62:2461 2465.
3. Freilich RJ, DeAngelis LM. Primary central nervous system lymphoma. Neurol Clin. 1995;13:901-914.
4. Dahlborg SA, Henner WD, Crossen JR, et al. Non-AIDS primary CNS lymphoma: the first example of a durable response in a primary brain tumor using enhanced chemotherapy delivery without cognitive loss and without radiotherapy. Cancer J Sc! Am. 1996;2:166-174.
5. Freilich RJ, Delattre JY, Monjour A, DeAngelis LM. Chemotherapy without radiation therapy as initial treatment for primary CNS lymphoma in older patients. Neurology. 1996:46:435-439.
6. Valluri S, Moorthy RS, Khan A, Rao NA. Combination treatment of intraocular lymphoma. Retina. 1995:15:125-129.
7. Peterson K, Gordon KB, Heinemann M, DeAngelis LM. The clinical spectrum of ocular lymphoma. Cancer. 1993:72:843-849.
8. Buettner H, Boiling JP. Intravitreal large-cell lymphoma. Mayo Clin Proc. 1993; 68:1011-1015.
9. Freeman LN, Schachat AP, Knox DL, Michels RG, Green WR. Clinical features, laboratory investigations, and survival in ocular reticulum cell sarcoma. Ophthalmology. 1987;94:1631-1639.
10. Wiedemann P, Lemmen K, Schmiedl R, Heimann K. Intraocular daunorubicin for the treatment and prophylaxis of traumatic proliferative vitreoretinopathy. Am J Ophthalmol. 1987;104:10-14.
11. Rootman J, Gudauskas G. Treatment of ocular leukemia with local chemotherapy. Cancer Treat Res. 1985:69:119-122.
12. de Smet MD, Stark-Vanes V, Kohler DR, Ruddel M, Wittes R, Nussenblatt RB. Intravitreal chemotherapy for intraocular lymphoma unresponsive to conventional therapeutic modalities. Ophthalmology. 1995;102:161. Abstract.
13. de Smet MD, Stark-Vanes V, Kohler DR, Smith J, Wittes R, Nussenblatt RB. Intraocular levels of methotrexate after intravenous administration. Am J Ophthalmol. 1996:121:442-444.
14. Wilson DJ, Braziel R, Rosenbaum JT. Intraocular lymphoma: immunopathologic analysis of vitreous biopsy specimens. Arch Ophthalmol. 1992;110:14551458.
15. Millay RH, Klein ML, Shults T, Dahlborg SA, Neuwelt EA. Maculopathy associated with combination chemotherapy and osmotic opening of the blood-brain barrier. Am J Ophthalmol. 1986;102:626-632.
16. Dean JM, Novak MA, Chan C, Green WR. Tumor detachments of the retinal pigment epithelium in ocular/central nervous system lymphoma. Retina. 1996;16: 47-56.